News

A recent discovery has lead to promising potential treatments for pancreatic cancer.

Data from the ChAdOx1 nCov-2019 coronavirus vaccine study suggests that one of the groups most vulnerable to serious illness and death from COVID-19, could build robust immunity following vaccination.

Short bursts of physical exercise induce changes in the body’s levels of metabolites that correlate to, and may help gauge, an individual’s cardiometabolic, cardiovascular and long-term health, a study by Massachusetts General Hospital (MGH) has found.

A team of MUSC researchers has found that the molecule lysyl oxidase (LOX) plays a number of important roles in promoting skin and organ fibrosis in scleroderma.

Monitoring how patients with multiple sclerosis or other degenerative diseases use their smartphones could provide valuable information to help get them better treatment.

A study has identified certain regions in the retina that are more affected by Alzheimer's disease than in other areas.

A simple and inexpensive blood test could pick out patients with stomach or oesophageal cancer who are likely to benefit from targeted treatment, a new study shows.

Fifty fragments of proteins, termed peptides, have been identified in the urine of liver fibrosis patients in a new study that could pave the way for a potential diagnostic urine test for the condition if further validated.

The new predictive tool has been developed by using an advanced microscopy platform that identifies the interactions between the immune cells and the tumor cells and also provides information about the activation state of the immune checkpoints that buffer the anti-tumor response.

Vital sign (VS) monitoring disruptions for hospitalized patients during overnight hours have been linked to cognitive impairment, hypertension, increased stress and even mortality. For the first time, researchers developed a deep-learning predictive clinical tool to identify which patients do not need to be woken up overnight — allowing them to recover faster.